Pasithea Therapeutics Corp. (KTTA)
0.5731
-0.01
(-1.26%)
USD |
NASDAQ |
Sep 04, 12:26
Pasithea Therapeutics Shareholders Equity (Quarterly) : 49.84M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.84M |
| March 31, 2026 | 54.81M |
| December 31, 2025 | 55.22M |
| September 30, 2025 | 12.21M |
| June 30, 2025 | 15.18M |
| March 31, 2025 | 12.98M |
| December 31, 2024 | 14.78M |
| September 30, 2024 | 17.81M |
| June 30, 2024 | 16.18M |
| March 31, 2024 | 19.88M |
| December 31, 2023 | 23.40M |
| Date | Value |
|---|---|
| September 30, 2023 | 28.37M |
| June 30, 2023 | 35.59M |
| March 31, 2023 | 39.14M |
| December 31, 2022 | 42.50M |
| September 30, 2022 | 46.79M |
| June 30, 2022 | 51.47M |
| March 31, 2022 | 49.98M |
| December 31, 2021 | 51.42M |
| September 30, 2021 | 16.48M |
| June 30, 2021 | 0.4701M |
| March 31, 2021 | 0.9007M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.71M |
| Total Liabilities (Quarterly) | 1.870M |
| Current Ratio | 26.25 |
| Net Debt Paydown Yield | 0.31% |